tiprankstipranks
Mydecine Innovations Group, Inc. (TSE:MYCO)
:MYCO
Canadian Market

Mydecine Innovations Group (MYCO) Financial Statements

Compare
97 Followers

Mydecine Innovations Group Financial Overview

Mydecine Innovations Group's market cap is currently C$617.55K. The company's EPS TTM is C$-0.274; its P/E ratio is ―; Mydecine Innovations Group is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit--$ 7.49K$ 2.62K$ 31.52K
Operating Income$ -9.55M$ -16.39M$ -22.68M$ -11.46M$ -3.39M
EBITDA$ -19.63M$ -16.20M$ -23.14M$ -26.64M$ -21.30M
Net Income$ -20.95M$ -11.57M$ -28.90M$ -26.95M$ -21.43M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 212.38K$ 6.90M$ 7.58M$ 9.53M$ 2.06M
Total Debt$ 5.42M$ 4.78M$ 4.50M$ 3.20M$ 62.38K
Net Debt$ 5.39M$ 153.26K$ 3.01M$ 1.01M$ 44.17K
Total Liabilities$ 12.13M$ 10.50M$ 7.37M$ 5.97M$ 231.30K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -4.22M$ -8.43M$ -24.34M$ -7.12M$ -1.49M
Operating Cash Flow$ -4.22M$ -8.43M$ -24.05M$ -7.12M$ -1.49M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Mydecine Innovations Group Earnings and Revenue History

Mydecine Innovations Group Debt to Assets

Mydecine Innovations Group Cash Flow

Mydecine Innovations Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis